The results demonstrated that IL-1β (Figure 4A) and IL-6 (Figure 4E) in Omicron-infected cancer patients were lower than those in non-Omicron-infected cancer patients (P <0.05) and higher than those in Omicron-infected non-cancer-afflicted subjects (P <0.01), respectively. The gene discussed is IL6; the disease is cancer.